| Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity KC Pao, NT Wood, A Knebel, K Rafie, M Stanley, PD Mabbitt, ... Nature 556 (7701), 381-385, 2018 | 206 | 2018 |
| The active site of O-GlcNAc transferase imposes constraints on substrate sequence S Pathak, J Alonso, M Schimpl, K Rafie, DE Blair, VS Borodkin, ... Nature structural & molecular biology 22 (9), 744-750, 2015 | 138 | 2015 |
| O-GlcNAc transferase inhibitors: current tools and future challenges R Trapannone, K Rafie, DMF Van Aalten Biochemical Society Transactions 44 (1), 88-93, 2016 | 100 | 2016 |
| Bisubstrate UDP–peptide conjugates as human O-GlcNAc transferase inhibitors VS Borodkin, M Schimpl, M Gundogdu, K Rafie, HC Dorfmueller, ... Biochemical Journal 457 (3), 497-502, 2014 | 76 | 2014 |
| Human species D adenovirus hexon capsid protein mediates cell entry through a direct interaction with CD46 BD Persson, L John, K Rafie, M Strebl, L Frängsmyr, MZ Ballmann, ... Proceedings of the National Academy of Sciences 118 (3), e2020732118, 2021 | 58 | 2021 |
| Recognition of a glycosylation substrate by the O-GlcNAc transferase TPR repeats K Rafie, O Raimi, AT Ferenbach, VS Borodkin, V Kapuria, DMF van Aalten Open biology 7 (6), 170078, 2017 | 58 | 2017 |
| The structure of enteric human adenovirus 41—A leading cause of diarrhea in children K Rafie, A Lenman, J Fuchs, A Rajan, N Arnberg, LA Carlson Science advances 7 (2), eabe0974, 2021 | 51 | 2021 |
| Thio-linked UDP–peptide conjugates as O-GlcNAc transferase inhibitors K Rafie, A Gorelik, R Trapannone, VS Borodkin, DMF van Aalten Bioconjugate chemistry 29 (6), 1834-1840, 2018 | 41 | 2018 |
| Direct monitoring of protein O-GlcNAcylation by high-resolution native mass spectrometry AC Leney, K Rafie, DMF Van Aalten, AJR Heck ACS chemical biology 12 (8), 2078-2084, 2017 | 28 | 2017 |
| UDP‐GlcNAc Analogues as Inhibitors of O‐GlcNAc Transferase (OGT): Spectroscopic, Computational, and Biological Studies M Ghirardello, D Perrone, N Chinaglia, D Sádaba, I Delso, T Tejero, ... Chemistry–A European Journal 24 (28), 7264-7272, 2018 | 16 | 2018 |
| O-GlcNAcase fragment discovery with fluorescence polarimetry VS Borodkin, K Rafie, N Selvan, T Aristotelous, I Navratilova, ... ACS chemical biology 13 (5), 1353-1360, 2018 | 10 | 2018 |
| Clinically observed deletions in SARS‐CoV‐2 Nsp1 affect its stability and ability to inhibit translation P Kumar, E Schexnaydre, K Rafie, T Kurata, I Terenin, V Hauryliuk, ... Febs Letters 596 (9), 1203-1213, 2022 | 4 | 2022 |
| Author Correction: The active site of O-GlcNAc transferase imposes constraints on substrate sequence S Pathak, J Alonso, M Schimpl, K Rafie, DE Blair, VS Borodkin, ... Nature structural & molecular biology 30 (4), 564, 2023 | | 2023 |
| Giardia intestinalis deoxyadenosine kinase has a unique tetrameric structure that enables high substrate affinity and makes the parasite sensitive to deoxyadenosine analogues F Ranjbarian, K Rafie, K Shankar, S Krakovka, SG Svärd, LA Carlson, ... bioRxiv, 2023.12. 18.572228, 2023 | | 2023 |
| Kinetics of the adenosine triphosphatase and helicase activity of the chikungunya virus polyprotein and nsP2 T Laurent, L Nenzén, K Rafie, LA Carlson | | 2023 |
| Clinically observed deletions in SARS-CoV-2 Nsp1 affect protein stability and its ability to inhibit translation P Kumar, E Schexnaydre, K Rafie, I Terenin, V Hauryliuk, LA Carlson bioRxiv, 2021.11. 03.467065, 2021 | | 2021 |
| Clinically observed deletions in SARS-CoV-2 Nsp1 affect protein stability and its ability to inhibit translation (preprint) P Kumar, E Schexnaydre, K Rafie, I Terenin, V Hauryliuk, LA Carlson | | 2021 |
| Developing O-GlcNAc Transferase Inhibitors: Insights from Substrate Recognition K Rafie University of Dundee, 2017 | | 2017 |
| Goblins: Bisubstrate inhibitors targeting the O-GlcNAc transferase K Rafie, V Borodkin, R Trapannone, DMF Van Aalten University of Dundee. College of Life Sciences 2015 Research Symposium, 2015 | | 2015 |
